Nelsen JL, Haas CE, Habtemariam B., et al. A prospective evaluation of propylene glycol clearance and accumulation during continuous-infusion lorazepam in critically ill patients. J Intensive Care Med. 2008;23:184-194.
2.
Arroliga AC, Shehab N., McCarthy K., Gonzales JPRelationship of continuous infusion lorazepam to serum propylene glycol concnetration in critically ill adults. Crit Care Med. 2004 ;32:1709-1714.
3.
Barnes BJ, Gerst G., Smith JR, Terrell AR, Mullins MEOsmol gap as a surrogate marker for serum propylene glycol concentrations in patients receiving lorazepam for sedation. Pharmacotherapy . 2006;26:23-33.
